Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi.
暂无分享,去创建一个
Nathan D. Montgomery | N. El-Mallawany | S. Gopal | Matthew S Painschab | Katherine D Westmoreland | T. Tomoka | B. Kaimila | Edwards Kasonkanji | Takondwa Zuze | M. Mulenga | P. Waswa | Y. Fedoriw | Matthew S. Painschab
[1] T. Gross,et al. How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa. , 2018, Blood.
[2] M. Horner,et al. Frequent HIV and Young Age Among Individuals With Diverse Cancers at a National Teaching Hospital in Malawi , 2018, Journal of global oncology.
[3] Nathan D Montgomery,et al. Practical Successes in Telepathology Experiences in Africa. , 2017, Clinics in laboratory medicine.
[4] T. van der Gronde,et al. Salvage chemotherapy for adults with relapsed or refractory lymphoma in Malawi , 2017, Infectious Agents and Cancer.
[5] Eva Steliarova-Foucher,et al. International incidence of childhood cancer, 2001–10: a population-based registry study , 2017, The Lancet. Oncology.
[6] N. El-Mallawany,et al. Quantifying bias in survival estimates resulting from loss to follow‐up among children with lymphoma in Malawi , 2017, Pediatric blood & cancer.
[7] D. Dittmer,et al. Hodgkin lymphoma, HIV, and Epstein–Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study , 2017, Pediatric blood & cancer.
[8] D. Dittmer,et al. Plasma Epstein‐Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi , 2017, International journal of cancer.
[9] R. Krysiak,et al. Accurate Real-Time Diagnosis of Lymphoproliferative Disorders in Malawi Through Clinicopathologic Teleconferences: A Model for Pathology Services in Sub-Saharan Africa. , 2016, American journal of clinical pathology.
[10] T. Uldrick,et al. Burkitt’s Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt’s Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital , 2016, Journal of global oncology.
[11] G. Salles,et al. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial , 2016, The Lancet.
[12] K. Richards,et al. CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi , 2016, PloS one.
[13] N. Rosenberg,et al. Outcomes for paediatric Burkitt lymphoma treated with anthracycline‐based therapy in Malawi , 2016, British journal of haematology.
[14] L. Staudt,et al. Low-intensity therapy in adults with Burkitt's lymphoma. , 2013, The New England journal of medicine.
[15] E. Hill,et al. Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. , 2012, Blood.
[16] C. Harrison,et al. Burkitt's lymphoma , 2012, The Lancet.
[17] E. Simard,et al. AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? , 2010, Blood.
[18] J. Esteve,et al. High‐dose chemotherapy and immunotherapy in adult Burkitt lymphoma , 2008, Cancer.
[19] C. Patte,et al. Treatment of B‐cell lymphoma with LMB modified protocols in Africa—report of the French‐African Pediatric Oncology Group (GFAOP) , 2008, Pediatric blood & cancer.
[20] É. Oksenhendler,et al. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. , 2007, Blood.
[21] G. Liomba,et al. Spectrum and presentation of pediatric malignancies in the HIV era: Experience from Blantyre, Malawi, 1998–2003 , 2007, Pediatric blood & cancer.
[22] S. Perkins,et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. , 2007, Blood.
[23] J. Goedert,et al. Trends in cancer risk among people with AIDS in the United States 1980–2002 , 2006, AIDS.
[24] H. Kantarjian,et al. Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia , 2006, Cancer.
[25] G. Leverger,et al. Francaise d ' Oncologie Pediatrique LMB 89 protocol : highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L 3 leukemia , 2001 .
[26] E. Jaffe,et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] D. Burkitt,et al. A sarcoma involving the jaws in african children , 1958, CA: a cancer journal for clinicians.
[28] G. Leverger,et al. The Socie ́ téFrançaise d ’ Oncologie Pe ́ diatrique LMB 89 protocol : highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L 3 leukemia , 2001 .